Last updated: August 24, 2021
Sponsor: Queen Sirikit National Institute of Child Health
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fever
Seizure Disorders
Treatment
N/AClinical Study ID
NCT04364321
QSNICH63-017
Ages 6-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- age 6-60 months at date of enrollment
- 3 or more episodes of clinically diagnosed febrile seizures
Exclusion
Exclusion Criteria:
- history of afebrile seizures or any history suggested the epilepsy
- history of previous brain insults; CNS infection, birth trauma, traumatic braininjury.
- delayed developmental milestones
- abnormal neurological examinations
- currently treatment by continous antiepileptic drug(s)
- A contraindication to Clonazepam, Diazepam such as drug hypersensitivity, liverdisease.
- Predictable lack of available of follow up.
Study Design
Total Participants: 74
Study Start date:
May 13, 2020
Estimated Completion Date:
June 30, 2023
Study Description
Connect with a study center
Queen Sirikit National Institute of Child Health
Ratchathewi, Bangkok 10400
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.